Today: 2 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Intel Stock (INTC) Today: Price, Government Stake and AI Foundry Outlook — November 25, 2025

Intel Stock (INTC) Today: Price, Government Stake and AI Foundry Outlook — November 25, 2025

Intel shares fell 0.8% to the mid-$35s Tuesday after a two-day rally, following a Q3 earnings beat, a new U.S. government equity stake, and major investments from Nvidia and SoftBank. The stock remains up about 45–50% over the past year but trades 16% below its October high. Q3 revenue reached $13.7 billion, with net income at $4.1 billion after a loss last year.
25 November 2025
Plug Power (PLUG) Stock on November 25, 2025: Price Action, $399M Cash Boost, and a High-Stakes Shareholder Vote

Plug Power (PLUG) Stock on November 25, 2025: Price Action, $399M Cash Boost, and a High-Stakes Shareholder Vote

Plug Power shares traded near $1.96 early Tuesday, down 1.5%, after a $399 million convertible-notes financing sparked volatility. The stock fell as much as 21% following the deal, which could add around 125 million shares if fully converted. Plug’s market cap stands at about $2.7 billion, far below its October high. A January vote may double the authorized share count.
OPEN Stock Today (11/25/2025): Opendoor Soars After Warrant Dividend, Fed Rate‑Cut Hopes and AI Pivot

OPEN Stock Today (11/25/2025): Opendoor Soars After Warrant Dividend, Fed Rate‑Cut Hopes and AI Pivot

Opendoor shares surged nearly 14% Monday, closing at about $7.69 after heavy trading volume topped 140 million shares. The rally followed a 17% drop last week and was fueled by Fed rate-cut hopes and a new special warrant dividend. Opendoor stock remains up several hundred percent in 2025 from a 52-week low of $0.51. The company’s market cap stands near $7.3 billion.
ONDS Stock Soars on Defense Robotics Deals: What Investors Need to Know on November 25, 2025

ONDS Stock Soars on Defense Robotics Deals: What Investors Need to Know on November 25, 2025

Ondas Holdings shares jumped 29.5% Monday to close at $8.72 after announcing a deal to acquire Roboteam, a tactical ground robotics firm. Early Tuesday trading showed ONDS fluctuating between $6.67 and $8.80. The company expects Roboteam to add at least $30 million in revenue in 2026. Ondas has also invested $35 million in Performance Drone Works and completed its Sentrycs acquisition.
NVDA Stock Today, November 25, 2025: Nvidia Whipsaws as Meta Eyes Google AI Chips and Wall Street Stays Bullish

NVDA Stock Today, November 25, 2025: Nvidia Whipsaws as Meta Eyes Google AI Chips and Wall Street Stays Bullish

Nvidia shares rebounded to $182.55, up about 2% midday Tuesday, after dropping 4% premarket on reports Meta may shift some AI workloads to Google’s chips. The move follows Nvidia’s record $57 billion quarterly revenue, up 62% year over year. Analyst 12-month price targets average $257. Competitive concerns remain as Meta weighs Google’s TPUs for future data centers.
Deere & Company (DE) Stock Today: Earnings on Deck as Shares Hover Near $487 – November 25, 2025

Deere & Company (DE) Stock Today: Earnings on Deck as Shares Hover Near $487 – November 25, 2025

Deere & Company shares closed at $487.23 on Monday, up 2.6% ahead of Wednesday’s fiscal Q4 2025 earnings release. The stock is up over 14% in 2025 but trades about 11% below its May high. Analysts expect Q4 EPS near $3.80, down from $4.55 a year ago, and revenue near $9.8 billion. Deere has tightened its 2025 net income outlook to $4.75–$5.25 billion.
AMPX Stock on November 25, 2025: Amprius Technologies Extends Rebound After Record Q3 Earnings and Korea Battery Alliance

AMPX Stock on November 25, 2025: Amprius Technologies Extends Rebound After Record Q3 Earnings and Korea Battery Alliance

Amprius Technologies shares traded around $10.80 Tuesday after a 6.8% jump Monday, with volume near 6.6 million. The stock remains volatile, down about 20% over the past ten sessions despite record Q3 revenue of $21.4 million and a narrower loss. Market cap stands at $1.3 billion. Most Q3 revenue came from aviation, especially UAVs.
LMT Stock Today (November 25, 2025): Lockheed Martin Slips Again as Record Backlog Meets Market Skepticism

LMT Stock Today (November 25, 2025): Lockheed Martin Slips Again as Record Backlog Meets Market Skepticism

Lockheed Martin shares fell 2.1% to about $451 in late Monday trading, extending a four-day losing streak despite the S&P 500 rising 1.55%. The company reported Q3 sales of $18.6 billion, a record $179 billion backlog, and raised its full-year outlook. Year to date, the stock is down just over 7% and 17% lower than a year ago. Trading volume topped 1.4 million shares, above recent averages.
AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

Axsome Therapeutics shares closed at $151.20 on Monday, near record highs, after reporting 63% year-over-year revenue growth in Q3 2025 to $171 million. The stock has climbed over 50% in the past year, valuing the company at about $7.6 billion. Net loss for the quarter narrowed to $47.2 million, or –$0.94 per share. Trading volume on Monday was roughly 540,000 shares.
25 November 2025
ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Altimmune shares traded near $5.10 on November 25, up about 20% over two weeks after Phase 2b data for lead drug pemvidutide was published in The Lancet and highlighted at AASLD. The stock remains down over 50% from its December 2024 high, with investor sentiment tempered by ongoing shareholder lawsuits and a new $400 million shelf registration.
Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Rheinmetall AG shares closed at €1,443.00 on Monday, down 5% and nearly 20% below early November highs, amid heavy trading volumes. The drop follows renewed hopes for peace in Ukraine, prompting investors to exit defense stocks. Despite the sell-off, Rheinmetall confirmed record order books and strong 2025 guidance. The stock remains up about 150% year-to-date.
SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Sarepta shares closed Monday at $18.90, up 6.9%, after a positive safety update for its experimental RNA therapy SRP‑1003. The company hit an enrollment milestone in its DM1 trial, triggering a $200 million payment to Arrowhead Pharmaceuticals. SRPT stock remains down about 85% year-to-date following setbacks with its gene therapy Elevidys.
RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. shares closed at $6.51 Monday, up 14.4% on heavy volume after Tether boosted its stake by 1.06 million shares and agreed to buy up to $150 million in GPU services. The stock has surged over 22% in two sessions but remains near the bottom of its 52-week range. Market cap stands near $2.5 billion.
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital (NASDAQ: NUAI) closed Monday at $4.40, up 15.8% after announcing its Texas AI data center campus will expand to 438 acres. Trading volume reached 8.6 million shares. Despite the rally, NUAI shares remain down about 62% over the past year. The company reported $0.84 million in revenue and a $23.5 million net loss for the past 12 months.
Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s named Michael J. Bender as permanent CEO on November 24, making him the fourth chief since 2018. Shares traded near $15.70 early Tuesday, valuing the company at about $1.8 billion, ahead of third-quarter earnings expected to show a loss and declining sales. Short interest stands at roughly 26–27% of float. The board declared a $0.125 per share dividend, payable December 24.
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell shares closed Monday at $127.22, up 3.8%, but remain down nearly 20% for the month and about 24% below their early-November high. Wall Street expects Q3 revenue near $27.2 billion and non-GAAP EPS around $2.48. Options imply a 9% post-earnings move. Project Maverick, Dell’s internal overhaul, faces a three-month delay due to scalability issues.
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics closed at $34.65 on November 24, valuing the company at about $3.9 billion. The firm completed enrollment in its Phase 3 obesity trial VANQUISH-1 ahead of schedule, with its lead drug VK2735 now in late-stage testing. Shares remain volatile, trading far below their 52-week high of $56.25 but well above the low of $18.92. Viking has no approved products or product revenue.
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer shares traded near $25 late Monday, valuing the company at about $143 billion, with a dividend yield of roughly 6.8%. Q3 2025 revenue fell 6% to $16.7 billion, as COVID product sales declined sharply, but non-COVID portfolio sales rose 4%. Adjusted EPS of $0.87 beat expectations by over 30%. Pfizer reaffirmed 2025 revenue guidance and raised its adjusted EPS outlook.
25 November 2025
1 670 671 672 673 674 679
Go toTop